# OnCo record paper-kurtz-nat-biotechnol (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-kurtz-nat-biotechnol/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-kurtz-nat-biotechnol" ;
  schema:name "Enhanced detection of minimal residual disease by targeted sequencing of phased variants in circulating tumor DNA"@en ;
  schema:description "Paper cited by one technology page, indexed on Europe PMC as PubMed record 34294911 and published in Nature Biotechnology; the citing page links this DOI, which is how the record was matched."@en ;
  schema:url <https://onco.cc/key-papers/paper-kurtz-nat-biotechnol/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1038/s41587-021-00981-w>, <https://pubmed.ncbi.nlm.nih.gov/34294911/>, <https://europepmc.org/article/MED/34294911> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1038/s41587-021-00981-w> ;
  schema:datePublished "2021"^^xsd:gYear ;
  schema:author "Kurtz DM, Soo J, Co Ting Keh L, et al." ;
  onco:related <https://onco.cc/technologies/ctdna-lymphoma-monitoring/> ;
  onco:journals <https://onco.cc/journals/nature-biotechnology/> .